Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 510

1.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
2.

Prenatal exposure to antidepressants: how safe are they?

Steiner M.

Am J Psychiatry. 2012 Nov;169(11):1130-2. doi: 10.1176/appi.ajp.2012.12081126. No abstract available.

PMID:
23128917
3.

Neurodevelopment of children prenatally exposed to selective reuptake inhibitor antidepressants: Toronto sibling study.

Nulman I, Koren G, Rovet J, Barrera M, Streiner DL, Feldman BM.

J Clin Psychiatry. 2015 Jul;76(7):e842-7. doi: 10.4088/JCP.14m09240.

PMID:
26231010
4.

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A.

Pediatrics. 2007 Jan;119(1):52-9.

PMID:
17200271
5.

No association between prenatal exposure to psychotropics and intelligence at age five.

Eriksen HL, Kesmodel US, Pedersen LH, Mortensen EL.

Acta Obstet Gynecol Scand. 2015 May;94(5):501-7. doi: 10.1111/aogs.12611. Epub 2015 Mar 17.

PMID:
25711407
6.

[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

de Moor RA, Mourad L, ter Haar J, Egberts AC.

Ned Tijdschr Geneeskd. 2003 Jul 12;147(28):1370-2. Dutch.

PMID:
12892015
7.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
8.

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, Mastroiacovo P, Addis A, Matsui D, Schuler L, Einarson TR, Koren G.

Am J Psychiatry. 2001 Oct;158(10):1728-30.

PMID:
11579012
9.

Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.

Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE.

Arch Pediatr Adolesc Med. 2010 May;164(5):444-51. doi: 10.1001/archpediatrics.2010.51.

PMID:
20439795
10.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
11.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
12.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
14.

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G.

Am J Psychiatry. 2002 Nov;159(11):1889-95.

PMID:
12411224
15.

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.

Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.

J Clin Psychopharmacol. 2012 Apr;32(2):186-94. doi: 10.1097/JCP.0b013e3182490eaf.

PMID:
22367660
16.

[Use of SSRIs during pregnancy and possible consequences for the development of the child].

van der Veere CN, Bos AF.

Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2873-4. Dutch.

PMID:
18257430
17.

Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.

Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE.

Arch Pediatr Adolesc Med. 2007 Jan;161(1):22-9.

PMID:
17199063
18.

SSRI antidepressants and persistent pulmonary hypertension in newborns.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):156.

PMID:
19492488
19.

Does fetal exposure to SSRIs or maternal depression impact infant growth?

Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.

Am J Psychiatry. 2013 May;170(5):485-93. doi: 10.1176/appi.ajp.2012.11121873. Erratum in: Am J Psychiatry. 2013 Oct 1;70(10):1218.

20.

Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.

Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.

Neuropsychopharmacology. 2014 Oct;39(11):2611-21. doi: 10.1038/npp.2014.114. Epub 2014 May 20.

Supplemental Content

Support Center